Pećin, Ivan Reiner, Željko
Published in
Journal of Experimental Pharmacology
Atherosclerotic cardiovascular diseases (ASCVD) are still the leading cause of morbidity and mortality in most developed countries and even more in developing countries. Dyslipidemia is a well known main risk factor for ASCVD. Lipid-lowering treatment, particularly lowering LDL-cholesterol (LDL-C), can decrease the risk for ASCVD. New data and guid...
Saunders, Isabel Bain, Stephen C
Published in
Diabetic medicine : a journal of the British Diabetic Association
A 45 year old woman with longstanding poorly controlled type 1 diabetes had recently been omitting insulin doses due to family stress. She presents with itchy skin-coloured papules on her buttocks and extensor surfaces of two weeks duration (Figure 1). Her HbA1c was 120 mmol/mol (13.1%) and she had declined statin therapy for hyperlipidaemia previo...
Tomlinson, Brian Lin, Chen-Hsiu Chan, Paul Lam, Christopher Wk
Published in
Personalized medicine
The choice of lipid-modifying treatment is largely based on the absolute level of cardiovascular risk and baseline lipid profile. Statins are the first-line treatment for most patients requiring reduction of low-density-lipoprotein cholesterol (LDL-C) and ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors can be added to reach L...
Ye, Shu Ran, Hui Zhang, Hongmei Wu, Hui Li, Wen Du, Shichun Su, Qing
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Purpose Ketosis-prone type 2 diabetes (KPT2D) is increasingly recognized in young adults. However, the role of blood lipids in KPT2D, especially serum triglycerides (TGs), is not yet clearly understood. Patients and Methods We retrospectively evaluated 409 young patients diagnosed with KPT2D or classical type 2 diabetes (T2D) attending an academic ...
Jewell, Dennis E. Panickar, Kiran S.
Published in
Frontiers in Veterinary Science
Forty Eight cats were used to measure the effects of feeding a traditional adult cat food supplemented with either arachidonic acid (ARA), a botanical mix (botanicals) or both on circulating biochemical parameters and inflammatory cytokines. The cats were healthy adults (mean age, 3.0; range, 1.3–6.4 years). The adult cats were fed one of four food...
Brelaz, K.C.B.T.R. Cruz, F.G.G. Rufino, J.P.F. Brasil, R.J.M. Silva, A.F. Santos, A.N.A.
ABSTRACT The present study aimed to evaluate increasing levels of fish waste oil in diets for laying hens on serum biochemistry profile. 192 Hisex White laying hens at 29 weeks of age were used, with water and food ad libitum. The experimental design was completely randomized consisting of eight treatments corresponding to the inclusion levels of f...
Ye, Yixuan Chen, Xi Han, James Jiang, Wei Natarajan, Pradeep Zhao, Hongyu
Published in
Circulation. Genomic and precision medicine
Both lifestyle and genetic factors confer risk for cardiovascular diseases, type 2 diabetes, and dyslipidemia. However, the interactions between these 2 groups of risk factors were not comprehensively understood due to previous poor estimation of genetic risk. Here we set out to develop enhanced polygenic risk scores (PRS) and systematically invest...
Lust, Cody A. C. Bi, Xinyan Henry, Christiani Jeyakumar Ma, David W. L.
Published in
Nutrients
Dietary fatty acids (FA) are essential for overall human health, yet individual FA reference ranges have yet to be established. Developing individual FA reference ranges can provide context to reported concentrations and whether an individual displays deficient, or excess amounts of FA. Reference ranges of sixty-seven individual FA (μmol/L) were pr...
Ambrosy, Andrew P. Malik, Umar I. Thomas, Rachel C. Parikh, Rishi V. Tan, Thida C. Goh, Choon H. Selby, Van N. Solomon, Matthew D. Avula, Harshith R. Fitzpatrick, Jesse K.
...
Published in
American Heart Journal
Objective The MITIGATE study aims to evaluate the real-world clinical effectiveness of pre-treatment with icosapent ethyl (IPE), compared with usual care, on laboratory-confirmed viral upper respiratory infection (URI)-related morbidity and mortality in adults with established atherosclerotic cardiovascular disease (ASCVD). Background IPE is a high...
Musunuru, Kiran
Statins, ezetimibe, and PCSK9 inhibitors are currently the standard of care for the prevention and treatment of coronary artery disease. Despite their widespread use, coronary artery disease remains the leading cause of death worldwide, a fact that pleads for the development of new protective therapies. In no small part due to advances in the field...